After cardiovascular disorders, cancer is the world 's second leading cause of mortality. The location of the cancer in the bodily organ determines the type of cancer. Different forms of cancer have different metabolic behaviors that are sometimes conflicting. Nonetheless, the oncogenic phenotype is supported by each cancer's unique metabolism. The immuno-biological microenvironments at distinct metastatic organ sites are major factors for variances in efficacy, and immunotherapy benefits a small proportion of patients across multiple cancer types. Recent advancements in cancer diagnosis and treatment, cancer survival has increased, and so there is a greater emphasis on quality rather than quantity of survival.
Title : JZJSZ
SAR9IKKD, Methodist Mansfield Medical Center, Azerbaijan
Title : hjhjk
sarika, hyghjk, American Samoa
Title : ghhyj
sarika, hyghjk, American Samoa